drugset / Trial / NCT05156606
Testosterone & Tamoxifen Trial
NaSingle-groupOpen-labelTreatment
Summary
This is a concise single arm, feasibility study, which will be executed in the University Medical Center Groningen, The Netherlands. Male patients with metastatic BC (n=6) are eligible for this study after at least 1 line of conventional endocrine therapy.
Timeline
- Start
- 2022-11-10
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | 50 mg | — |